Expert Opinion on Drug Delivery

Pulmonary delivery of nucleic acids
pp. 575-578(4)
Author: Birchall, James

Vesicles as tools for the modulation of skin permeability
pp. 579-593(15)
Authors: Dubey, Vaibhav; Mishra, Dinesh; Nahar, Manoj; Jain, Narendra K

The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects
pp. 595-606(12)
Authors: Rogueda, Philippe GA; Traini, Daniela

The nanoscale in pulmonary delivery. Part 2: formulation platforms
pp. 607-620(14)
Authors: Rogueda, Philippe GA; Traini, Daniela

Advances and challenges of nanotechnology-based drug delivery systems
pp. 621-633(13)
Authors: Jiang, Wen; Kim, Betty YS; Rutka, James T; Chan, Warren CW

Controlled release systems of angiogenic growth factors for cardiovascular diseases
pp. 635-649(15)
Authors: Esaki, Jiro; Marui, Akira; Tabata, Yasuhiko; Komeda, Masashi

Design of nanoparticle-based dry powder pulmonary vaccines
pp. 651-663(13)
Authors: Pulliam, Brian; Sung, Jean C; Edwards, David A

Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs
pp. 665-675(11)
Authors: Lacko, Andras G; Nair, Maya; Prokai, Laszlo; McConathy, Walter J

Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections
pp. 677-688(12)
Authors: Gamazo, Carlos; Prior, Sandra; Concepción Lecároz, María; Vitas, Ana Isabel; Campanero, Miguel Angel; Pérez, Guiomar; Gonzalez, David; Blanco-Prieto, María Jose

Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance
pp. 689-701(13)
Authors: Berger, William E; Godfrey, James W; Slater, Anna L